We supposed this may be due to the fact that CX3CL1 levels are increased in the explorative cohort as a reflection of an anti-inflammatory protective effect, thus it is reasonable that there is an elevated trend in the early stages of PD and a decrease as the disease progresses.
← all excerpts
Parkinson's disease peripheral immune biomarker profile: a multicentre, cross-sectional and longitudinal study.
1
—
—